Long Term Open-label Study Evaluating Safety of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex
Clinical trial NCT03389308 · COMPLETED
Trial details
- NCT number
- NCT03389308
- Sponsor
- Castle Creek Pharmaceuticals, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-01
- Primary completion
- 2020-04-17
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.